Sanofi’s France-Based API Company Could Reduce Reliance On China

Sanofi’s plans to open up a new company in Europe focused on making and marketing active pharmaceutical ingredients to third-party drug manufacturers would be a boon to the pharmaceutical supply chain and make it less susceptible to region-specific challenges, according to Michael Ganio, director of pharmacy, practice and quality at the American Society of Health-System Pharmacists. The company’s Monday (Feb. 24) announcement that it will set up a new API-focused entity comes as concerns about the spread of coronavirus in...